Literature DB >> 17413865

Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease.

Babette S Zemel1, Deborah A Kawchak, Kwaku Ohene-Frempong, Joan I Schall, Virginia A Stallings.   

Abstract

Previous studies of children with sickle cell disease (SCD) reported poor growth and delayed maturation. However, the prevalence, magnitude, and correlates of suboptimal growth remain poorly understood. A prospective longitudinal study was undertaken to determine the effects of disease severity and nutritional status on growth, an indicator of childhood well-being. Children, birth to 18 y of age, with SCD-SS were evaluated annually for 4 y. Growth, nutritional status, skeletal and sexual maturation, disease severity, dietary intake, and maternal education were assessed. In this sample of 148 children (78 females), growth in height, weight, or body mass index declined in 84% of subjects; 38% fell below the 5th percentile in one or more measures. Puberty was delayed 1 to 2 y, and median age at menarche was 13.2 y. Skeletal age was delayed by 0.7 +/- 1.4 y overall and by 1.3 +/- 1.5 y in children 10 to 15 y old. Height status declined over time and was positively associated with advancing puberty and hematological measures in girls, and nutritional status in girls and boys. Growth failure and maturational delay remain significant chronic problems in children with SCD-SS and are related to potentially modifiable factors such as nutritional status.

Entities:  

Mesh:

Year:  2007        PMID: 17413865     DOI: 10.1203/pdr.0b013e318045bdca

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  40 in total

1.  Cognitive functioning in children from Nigeria with sickle cell anemia.

Authors:  Olubusola B Oluwole; Robert B Noll; Daniel G Winger; Olu Akinyanju; Enrico M Novelli
Journal:  Pediatr Blood Cancer       Date:  2016-07-09       Impact factor: 3.167

2.  Hydroxyurea and growth in young children with sickle cell disease.

Authors:  Sohail Rana; Patricia E Houston; Winfred C Wang; Rathi V Iyer; Jonathan Goldsmith; James F Casella; Caroline K Reed; Zora R Rogers; Myron A Waclawiw; Bruce Thompson
Journal:  Pediatrics       Date:  2014-09       Impact factor: 7.124

3.  Assessment of bone remodelling in childhood-onset systemic lupus erythematosus.

Authors:  Julie C Baker-LePain; Mary C Nakamura; John Shepherd; Emily von Scheven
Journal:  Rheumatology (Oxford)       Date:  2010-11-23       Impact factor: 7.580

4.  Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis.

Authors:  Jifang Zhou; Jin Han; Edith A Nutescu; William L Galanter; Surrey M Walton; Victor R Gordeuk; Santosh L Saraf; Gregory S Calip
Journal:  Br J Haematol       Date:  2019-02-03       Impact factor: 6.998

5.  Sickle cell disease is associated with decreased HIV but higher HBV and HCV comorbidities in U.S. hospital discharge records: a cross-sectional study.

Authors:  Mehdi Nouraie; Sergei Nekhai; Victor R Gordeuk
Journal:  Sex Transm Infect       Date:  2012-05-24       Impact factor: 3.519

6.  Genetic factors are important determinants of impaired growth after infant cardiac surgery.

Authors:  Nancy Burnham; Richard F Ittenbach; Virginia A Stallings; Marsha Gerdes; Elaine Zackai; Judy Bernbaum; Robert R Clancy; J William Gaynor
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04-09       Impact factor: 5.209

7.  Menarche in pediatric patients with Crohn's disease.

Authors:  Neera Gupta; Robert H Lustig; Michael A Kohn; Eric Vittinghoff
Journal:  Dig Dis Sci       Date:  2012-06-29       Impact factor: 3.199

8.  Upper airway lymphoid tissue size in children with sickle cell disease.

Authors:  Temima Strauss; Sanghun Sin; Carole L Marcus; Thornton B A Mason; Joseph M McDonough; Julian L Allen; Jason B Caboot; Cheryl Y Bowdre; Abbas F Jawad; Kim Smith-Whitley; Kwaku Ohene-Frempong; Allan I Pack; Raanan Arens
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

Review 9.  Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease.

Authors:  Satheesh Chonat; Charles T Quinn
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

10.  TNF-α, IFN-γ, IL-10, and IL-4 levels were elevated in a murine model of human sickle cell anemia maintained on a high protein/calorie diet.

Authors:  Hyacinth I Hyacinth; Patrice L Capers; David R Archer; Jacqueline M Hibbert
Journal:  Exp Biol Med (Maywood)       Date:  2013-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.